Cite
HARVARD Citation
Acevedo-Gadea, C. et al. (2014). Phase I Clinical Trial of the Mammalian Target of Rapamycin Inhibitor Everolimus in Combination With Oral Topotecan for Recurrent and Advanced Endometrial Cancer. International journal of gynecological cancer. 24 (3), pp. 528-533. [Online].